Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension: Relation with the development of hypertensive end-stage renal disease

American Journal of Hypertension

Volumn 18, Issue 11, 2005, Pages 1442-1448

  Tylicki, Leszek ^a   Födinger, Manuela ^b   Puttinger, Heidemarie ^b   Rutkowski, Przemyslaw ^a   Strozecki, Pawel ^c   Tyszko, Sylwia ^a   Rutkowski, Boleslaw ^a   Hörl, Walter H ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Essential hypertension; Homocysteine; Hypertensive nephropathy; MTHFR; Polymorphism

Indexed keywords

HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGE DISTRIBUTION; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; GENOTYPE; HUMAN; KIDNEY INJURY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL ANALYSIS;

ALLELES; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS;

EID: 27644594247     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.05.012     Document Type: Article

References (38)

1. B. Rutkowski, L. Tylicki, J. Manitius, W. Lysiak-Szydlowska Hypertensive nephropathy - An increasing clinical problem Miner Electrolyte Metab 25 1999 65 68
2. L. Tylicki, B. Rutkowski, W. Horl Multifactorial determination of hypertensive nephroangiosclerosis Kidney Blood Press Res 25 2002 241 353
3. P.C. Churchill, M.C. Churchill, A.K. Bidani, K.A. Griffin, M. Picken, M. Pravenec, V. Kren, E. St Lezin, J.M. Wang, N. Wang, T.W. Kurtz Genetic susceptibility to hypertension-induced renal damage in the rat Evidence based on kidney-specific genome transfer J Clin Invest 100 1997 1373 1382
4. E. St Lezin, K.A. Griffin, M. Picken, M.C. Churchill, P.C. Churchill, T.W. Kurtz, W. Liu, N. Wang, V. Kren, V. Zidek, M. Pravenec, A.K. Bidani Genetic isolation of a chromosome 1 region affecting susceptibility to hypertension-induced renal damage in the spontaneously hypertensive rat Hypertension 34 1999 187 191
5. D.M. Brown, A.P. Provoost, M.J. Daly, E.S. Lander, H.J. Jacob Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat Nat Genet 12 1996 44 51
6. System EfUSRD 1999 Annual Data Report Am J Kidney Dis 34 1999 S1 S176
7. M.J. Klag, P.K. Whelton, B.L. Randall, J.D. Neaton, F.L. Brancati, J. Stamler End-stage renal disease in African-American and white men. 16-year MRFIT findings JAMA 277 1997 1293 1298
8. B.I. Freedman, J.M. Soucie, W.M. McClellan Family history of end-stage renal disease among incident dialysis patients J Am Soc Nephrol 8 1997 1942 1945
9. D.F. O'Dea, S.W. Murphy, D. Hefferton, P.S. Parfrey Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease a population-based study Am J Kidney Dis 32 1998 794 801
10. F. Mallamaci, A. Zuccala, C. Zoccali, A. Testa, R. Gaggi, B. Spoto, C. Martorano, A. Curatola, V. Misefari, F. Cuzzola, G. Romeo, P. Zucchelli The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis Am J Hypertens 13 2000 433 437
11. P. Fernandez-Llama, E. Poch, J. Oriola, A. Botey, E. Coll, A. Darnell, F. Rivera, L. Revert Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis Kidney Int 53 1998 1743 1747
12. R. Clarke, L. Daly, K. Robinson, E. Naughten, S. Cahalane, B. Fowler, I. Graham Hyperhomocysteinemia an independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
13. G.Y. Lip, E. Edmunds, S.C. Martin, A.F. Jones, A.D. Blann, D.G. Beevers A pilot study of homocyst(e)ine levels in essential hypertension relationship to von Willebrand factor, an index of endothelial damage Am J Hypertens 14 2001 627 631
14. N. Li, Y.F. Chen, A.P. Zou Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension Hypertension 39 2002 443 448
15. P.F. Jacques, A.G. Bostom, R.R. Williams, R.C. Ellison, J.H. Eckfeldt, I.H. Rosenberg, J. Selhub, R. Rozen Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations Circulation 93 1996 7 9
16. N.M. van der Put, F. Gabreels, E.M. Stevens, J.A. Smeitink, F.J. Trijbels, T.K. Eskes, L.P. van den Heuvel, H.J. Blom A second common mutation in the methylenetetrahydrofolate reductase gene an additional risk factor for neural-tube defects? Am J Hum Genet 62 1998 1044 1051
17. P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, R.G. Matthews, G.J. Boers, M. den Heijer, L.A. Kluijtmans, L.P. van den Heuvel A candidate genetic risk factor for vascular disease a common mutation in methylenetetrahydrofolate reductase Nat Genet 10 1995 111 113
18. I. Weisberg, P. Tran, B. Christensen, S. Sibani, R. Rozen A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity Mol Genet Metab 64 1998 169 172
19. S.R. Lentz, M.R. Malinow, D.J. Piegors, M. Bhopatkar-Teredesai, F.M. Faraci, D.D. Heistad Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys Arterioscler Thromb Vasc Biol 17 1997 2930 2934
20. J.C. Tsai, M.A. Perrella, M. Yoshizumi, C.M. Hsieh, E. Haber, R. Schlegel, M.E. Lee Promotion of vascular smooth muscle cell growth by homocysteine a link to atherosclerosis Proc Natl Acad Sci USA 91 1994 6369 6373
21. A. Majors, L.A. Ehrhart, E.H. Pezacka Homocysteine as a risk factor for vascular disease Enhanced collagen production and accumulation by smooth muscle cells Arterioscler Thromb Vasc Biol 17 1997 2074 2081
22. V.B. Schini-Kerth Homocysteine, a proinflammatory and proatherosclerotic factor role of intracellular reactive oxygen species Circ Res 93 2003 271 273
23. J. Loscalzo The oxidant stress of hyperhomocyst(e)inemia J Clin Invest 98 1996 5 7
24. H. Kumagai, S. Katoh, K. Hirosawa, M. Kimura, A. Hishida, N. Ikegaya Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia Kidney Int 62 2002 1219 1228
25. A. Vychytil, M. Födinger, G. Wolfl, B. Enzenberger, M. Auinger, F. Prischl, M. Buxbaum, M. Wiesholzer, C. Mannhalter, W.H. Hörl, G. Sunder-Plassmann Major determinants of hyperhomocysteinemia in peritoneal dialysis patients Kidney Int 53 1998 1775 1782
26. D.L. Harmon, J.V. Woodside, J.W. Yarnell, D. McMaster, I.S. Young, E.E. McCrum, K.F. Gey, A.S. Whitehead, A.E. Evans The common "thermolabile" variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia QJM 89 1996 571 577
27. M. Födinger, C. Mannhalter, G. Wolfl, I. Pabinger, E. Muller, R. Schmid, W.H. Hörl, G. Sunder-Plassmann Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients Kidney Int 52 1997 517 523
28. M. Födinger, G. Wolfl, G. Fischer, S. Rasoul-Rockenschaub, R. Schmid, W.H. Hörl, G. Sunder-Plassmann Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients Kidney Int 55 1999 1072 1080
29. P.J. Bagley, J. Selhub A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells Proc Natl Acad Sci USA 95 1998 13217 13220
30. M. Rauh, S. Verwied, I. Knerr, H.G. Dorr, A. Sonnichsen, B. Koletzko Homocysteine concentrations in a German cohort of 500 individuals reference ranges and determinants of plasma levels in healthy children and their parents Amino Acids 20 2001 409 418
31. J. Golbahar, G. Rezaian, H. Bararpour Distribution of plasma total homocysteine concentrations in the healthy Iranians Clin Biochem 37 2004 149 151
32. O. Viklicky, J.A. Hubacek, J. Kvasnicka, I. Matl, L. Voska, J. Skibova, V. Teplan, S. Vitko Association of methylenetetrahydrofolate reductase T677 allele with early development of chronic allograft nephropathy Clin Biochem 37 2004 919 924
33. N.S. Shcherbak, Z.V. Shutskaya, A.M. Sheidina, V.I. Larionova, E.I. Schwartz Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients Mol Genet Metab 68 1999 375 378
34. Y. Makita, D.K. Moczulski, J. Bochenski, A.M. Smiles, J.H. Warram, A.S. Krolewski Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes Am J Kidney Dis 41 2003 1189 1194
35. H. Fujita, T. Narita, H. Meguro, T. Ishii, O. Hanyu, K. Suzuki, K. Kamoi, S. Ito No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type II diabetic patients with proliferative diabetic retinopathy J Diabetes Complications 13 1999 284 287
36. M.J. Zychma, J. Gumprecht, W. Grzeszczak, E. Zukowska-Szczechowska Methylenetetrahydrofolate reductase gene C677T polymorphism, plasma homocysteine and folate in end-stage renal disease dialysis and non-dialysis patients Nephron 92 2002 235 239
37. M. Ravera, F. Viazzi, V. Berruti, G. Leoncini, P. Zagami, G.P. Bezante, N. Rosatto, R. Ravazzolo, R. Pontremoli, G. Deferrari 5,10- Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension Am J Hypertens 14 2001 371 376
38. S.D. Schlessinger, M.R. Tankersley, J.J. Curtis Clinical documentation of end-stage renal disease due to hypertension Am J Kidney Dis 23 1994 655 660